Clinical studies of granulocyte-macrophage colony stimulating factor.
Gutterman
J
J
Department of Clinical Immunology and Biological Therapy, University of Texas System Cancer Center M.D. Anderson Hospital and Tumor Institute, Houston 77030.
D000741:Anemia, Aplastic / Q000628:therapy; D000753:Anemia, Refractory / Q000628:therapy; D003115:Colony-Stimulating Factors / Q000009:adverse effects / Q000627:therapeutic use*; D004341:Drug Evaluation; D016178:Granulocyte-Macrophage Colony-Stimulating Factor; D006133:Growth Substances / Q000009:adverse effects / Q000627:therapeutic use*; D006402:Hematologic Diseases / Q000209:etiology / Q000628:therapy*; D006801:Humans; D009369:Neoplasms / Q000097:blood; D011994:Recombinant Proteins / Q000009:adverse effects / Q000627:therapeutic use
D003115:Colony-Stimulating Factors; D006133:Growth Substances; D011994:Recombinant Proteins; D016178:Granulocyte-Macrophage Colony-Stimulating Factor